Katrien Van Bocxlaer

Author

London School of Hygiene & Tropical Medicine ORCID

Also Known As

Katrien Van Bocxlaer, Katrien van Bocxlaer

Publications

837

Citations

H-Index

Concepts

All Affiliations

London School of Hygiene & Tropical Medicine University College London University of York The London College Pharmidex (United Kingdom)

About

Katrien Van Bocxlaer is an author at London School of Hygiene & Tropical Medicine specializing in drug discovery, parasitology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	93
2	Immunology	2	2	93
3	Pharmacology	2	2	93
4	Drug Discovery	2	2	93
5	Pathology	1	1	20

Katrien Van Bocxlaer

Publications

631

Citations

H-Index

Page 1

	Year	Citations
Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis Alaa Riezk, Katrien Van Bocxlaer, Vanessa Yardley, Molecules	2020	78
Tackling Drug Resistance and Other Causes of Treatment Failure in Leishmaniasis Gert-Jan Wijnant, Franck Dumetz, Laura Dirkx, Frontiers in Tropical Diseases Disease ResistanceOther CausesAntiparasitic AgentImmunotherapyDrug Discovery	2022	73
Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis Katrien Van Bocxlaer, Diana Caridha, Chad Black, International Journal for Parasitology Drugs and Drug Resistance	2019	64
Characterization of a new Leishmania major strain for use in a controlled human infection model Helen Ashwin, Jovana Sádlová, Barbora Vojtková, Nature Communications	2021	50
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome® and AmBisome® in murine cutaneous leishmaniasis Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, International Journal for Parasitology Drugs and Drug Resistance	2018	47
Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model Katrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, Journal of Pharmacy and Pharmacology	2016	45
Drug permeation and barrier damage in<i>Leishmania</i>-infected mouse skin Katrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan, Journal of Antimicrobial Chemotherapy	2016	44
Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles Katrien Van Bocxlaer, Eric Gaukel, Deirdre Hauser, Antimicrobial Agents and Chemotherapy	2018	39
Pharmacokinetics and Pharmacodynamics of the Nitroimidazole DNDI-0690 in Mouse Models of Cutaneous Leishmaniasis Gert-Jan Wijnant, Simon L. Croft, Raúl de la Flor, Antimicrobial Agents and Chemotherapy	2019	39
Relation between Skin Pharmacokinetics and Efficacy in AmBisome Treatment of Murine Cutaneous Leishmaniasis Gert-Jan Wijnant, Katrien Van Bocxlaer, Vanessa Yardley, Antimicrobial Agents and Chemotherapy	2017	34

Page 1